A recent study indicates that individuals who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide may regain shed pounds much more quickly than those who halt conventional diet and exercise regimens.
Research printed in a leading medical journal points out that while overweight people frequently drop substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Users using these medications must be informed of the danger of fast weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.
This pace of recovery means a reversion to pre-treatment weight in about a year and a half.
Comparing Therapies
The research, which examined dozens of trials involving thousands of patients, contrasted the results of the injectable medications with other pills.
Researchers note that people who lose weight through dieting usually experience a less rapid creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Quick Regain
Doctors believe the way of the injections accounts for the amplified regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations far above than normal may cause the system to produce less of its endogenous hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating a significant risk."
A Lifelong Disease?
Health authorities advise the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals argue that, due to the likelihood of weight regain, the treatment is often life-long.
This view is reinforced by pharmaceutical companies, who state that the findings "underscore the chronic nature of excess weight," similar to managing diseases like diabetes.
User Testimonies
People who have discontinued the jabs report a powerful resurgence of cravings.
"I experienced something that goes on and I was suddenly ravenous," said an individual.
This difficulty is worsened if users have not established sustainable dietary or behavioural modifications during therapy.
Significant Interest
Recent estimates show that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.
- Use is greater among females compared to men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts caution that while the jabs are potent agents for shedding pounds, they are not a standalone solution and maintained weight loss hinges on integrated behavioural support.
